| May 1, 2012 |
May 1, 2012
Cerus Corporation Reports First Quarter 2012 Results
|
| April 30, 2012 |
April 30, 2012
Cerus, the University Hospitals of Geneva, and the Transfusion Service of the Swiss Red Cross Intend to Collaborate on Whole Blood Pathogen Inactivation for Africa
|
| April 24, 2012 |
April 24, 2012
Cerus and New York Blood Center to Collaborate on Development of Novel Red Blood Cell Biologic Product with Improved Uniformity
|
| April 18, 2012 |
April 18, 2012
Cerus Announces First INTERCEPT Platelet System Customer in Austria
|
| April 12, 2012 |
April 12, 2012
Cerus to Release First Quarter 2012 Results on May 1, 2012
|
| April 3, 2012 |
April 3, 2012
Cerus Announces New Supply Agreement with Largest Blood Service in Saudi Arabia
|
| March 21, 2012 |
March 21, 2012
Cerus Submits Investigational Device Exemption (IDE) Supplement to FDA for Phase III INTERCEPT Red Blood Cell Study
|
| February 29, 2012 |
February 29, 2012
Cerus to Present at the Cowen and Company 32nd Annual Healthcare Conference on March 7, 2012
|
| February 28, 2012 |
February 28, 2012
Cerus Corporation Reports Fourth Quarter and Year-End 2011 Results
|
| February 6, 2012 |
February 6, 2012
Cerus to Present at the 14th Annual BIO CEO & Investor Conference on February 13, 2012
|
| February 2, 2012 |
February 2, 2012
Cerus to Release Fourth Quarter and Year-End 2011 Results on February 28, 2012
|
| February 1, 2012 |
February 1, 2012
Cerus and Ilex BioTech Report INTERCEPT Platelet and Plasma System Approvals in Israel
|
| January 9, 2012 |
January 9, 2012
Cerus Appoints Andrew Gomperts as Chief Business Officer
|